Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Ribera J, Zamora L, Morgades M, Vives S, Granada I, Montesinos P, Gómez-Seguí I, Mercadal S, Guàrdia R, Nomdedeu J, Pratcorona M, Tormo M, Martínez-Lopez J, Hernández-Rivas JM, Ciudad J, Orfao A, González-Campos J, Barba P, Escoda L, Esteve J, Genescà E, Solé F, Feliu E, Ribera JM; Spanish PETHEMA Group; Spanish Society of Hematology.

Genes Chromosomes Cancer. 2019 Nov;58(11):815-819. doi: 10.1002/gcc.22788. Epub 2019 Aug 7.

PMID:
31340073
2.

Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms.

Acha P, Xandri M, Fuster-Tormo F, Palomo L, Xicoy B, Cabezón M, Marcé S, Granada I, Vela D, Sagüés M, Boque C, Plensa E, Pineda A, Feliu E, Solé F, Zamora L.

Am J Hematol. 2019 Oct;94(10):E264-E267. doi: 10.1002/ajh.25580. Epub 2019 Aug 6. No abstract available.

PMID:
31321810
3.

The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients.

Ribera J, Granada I, Morgades M, Vives S, Genescà E, González C, Nomdedeu J, Escoda L, Montesinos P, Mercadal S, Coll R, González-Campos J, Abella E, Barba P, Bermúdez A, Gil C, Tormo M, Pedreño M, Martínez-Carballeira D, Hernández-Rivas JM, Orfao A, Martínez-López J, Esteve J, Bravo P, Garcia-Guiñon A, Debén G, Moraleda JM, Queizán JA, Ortín X, Moreno MJ, Feliu E, Solé F, Ribera JM; PETHEMA Group, Spanish Society of Haematology.

Br J Haematol. 2019 Jul;186(2):263-268. doi: 10.1111/bjh.15887. Epub 2019 Mar 27.

PMID:
30916384
4.

Population-based incidence of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain.

Solans M, Fàbrega A, Morea D, Auñon-Sanz C, Granada I, Roncero JM, Blanco A, Kelleher N, Buch J, Saez M, Marcos-Gragera R.

Cancer Epidemiol. 2019 Feb;58:8-11. doi: 10.1016/j.canep.2018.11.001. Epub 2018 Nov 10.

PMID:
30423540
5.

Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.

Schanz J, Solé F, Mallo M, Luño E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D.

Genes Chromosomes Cancer. 2018 Nov;57(11):547-556. doi: 10.1002/gcc.22667. Epub 2018 Sep 24.

PMID:
30248204
6.

Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group.

Nomdedeu M, Pereira A, Calvo X, Colomer J, Sole F, Arias A, Gomez C, Luño E, Cervera J, Arnan M, Pomares H, Ramos F, Oiartzabal I, Espinet B, Pedro C, Arrizabalaga B, Blanco ML, Tormo M, Hernandez-Rivas JM, Díez-Campelo M, Ortega M, Valcárcel D, Cedena MT, Collado R, Grau J, Granada I, Sanz G, Campo E, Esteve J, Costa D; Spanish MDS Group.

Leuk Res. 2017 Dec;63:85-89. doi: 10.1016/j.leukres.2017.10.011. Epub 2017 Oct 28.

PMID:
29121539
7.

Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.

Ribera J, Zamora L, Morgades M, Mallo M, Solanes N, Batlle M, Vives S, Granada I, Juncà J, Malinverni R, Genescà E, Guàrdia R, Mercadal S, Escoda L, Martinez-Lopez J, Tormo M, Esteve J, Pratcorona M, Martinez-Losada C, Solé F, Feliu E, Ribera JM; Spanish PETHEMA Group and the Spanish Society of Hematology.

Genes Chromosomes Cancer. 2017 Nov;56(11):810-820. doi: 10.1002/gcc.22486. Epub 2017 Aug 26.

PMID:
28758283
8.

Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.

Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Mercadal S, González-Campos J, Moreno MJ, Barba P, Cervera M, Barrios M, Novo A, Bernal T, Hernández-Rivas JM, Abella E, Amigo ML, Tormo M, Martino R, Lavilla E, Bergua J, Serrano A, García-Belmonte D, Guàrdia R, Grau J, Feliu E; PETHEMA Group, Spanish Society of Hematology.

Leuk Lymphoma. 2018 Jan;59(1):146-154. doi: 10.1080/10428194.2017.1326596. Epub 2017 May 30.

PMID:
28554259
9.

Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance.

Baptista MJ, Granada I, Morgades M, Calasanz MJ, Canals J, Robles De Castro D, Luño E, Ruiz-Xivillé N, Rodríguez-Hernández I, González T, Terol MJ, Valiente A, Ortuño F, Garcia-Malo MD, Piñan MÁ, Oliveira AC, Talavera M, Buño I, Batlle-López A, Moreno C, Ferra C, Solé F.

Am J Hematol. 2017 Jul;92(7):E132-E135. doi: 10.1002/ajh.24754. Epub 2017 Jun 1. No abstract available.

10.

Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia.

Palau A, Mallo M, Palomo L, Rodríguez-Hernández I, Diesch J, Campos D, Granada I, Juncà J, Drexler HG, Solé F, Buschbeck M.

Genes Chromosomes Cancer. 2017 Mar;56(3):243-252. doi: 10.1002/gcc.22430. Epub 2016 Nov 21.

PMID:
27750403
11.

Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.

Muñoz-López A, Romero-Moya D, Prieto C, Ramos-Mejía V, Agraz-Doblas A, Varela I, Buschbeck M, Palau A, Carvajal-Vergara X, Giorgetti A, Ford A, Lako M, Granada I, Ruiz-Xivillé N, Rodríguez-Perales S, Torres-Ruíz R, Stam RW, Fuster JL, Fraga MF, Nakanishi M, Cazzaniga G, Bardini M, Cobo I, Bayon GF, Fernandez AF, Bueno C, Menendez P.

Stem Cell Reports. 2016 Oct 11;7(4):602-618. doi: 10.1016/j.stemcr.2016.08.013. Epub 2016 Sep 22.

12.

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.

Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Brunet S, Bergua J, Tormo M, García-Boyero R, Sarrà J, Del Potro E, Grande C, Barba P, Bernal T, Amigo ML, Grau J, Cervera J, Feliu E; PETHEMA Group, Spanish Society of Hematology.

Leuk Lymphoma. 2017 Jan;58(1):145-152. Epub 2016 Apr 27.

PMID:
27122129
13.

Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.

Baliakas P, Puiggros A, Xochelli A, Sutton LA, Nguyen-Khac F, Gardiner A, Plevova K, Minga E, Hadzidimitriou A, Walewska R, McCarthy H, Ortega M, Collado R, González T, Granada I, Luño E, Kotašková J, Moysiadis T, Davis Z, Stavroyianni N, Anagnostopoulos A, Strefford JC, Pospisilova S, Davi F, Athanasiadou A, Rosenquist R, Oscier D, Espinet B, Stamatopoulos K.

Haematologica. 2016 Jul;101(7):e299-302. doi: 10.3324/haematol.2015.140202. Epub 2016 Apr 21. No abstract available.

14.

A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma.

Cantariño N, Fernández-Figueras MT, Valero V, Musulén E, Malinverni R, Granada I, Goldie SJ, Martín-Caballero J, Douet J, Forcales SV, Buschbeck M.

Int J Cancer. 2016 Sep 1;139(5):1106-16. doi: 10.1002/ijc.30139. Epub 2016 May 5.

15.

Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.

Bueno C, Sardina JL, Di Stefano B, Romero-Moya D, Muñoz-López A, Ariza L, Chillón MC, Balanzategui A, Castaño J, Herreros A, Fraga MF, Fernández A, Granada I, Quintana-Bustamante O, Segovia JC, Nishimura K, Ohtaka M, Nakanishi M, Graf T, Menendez P.

Leukemia. 2016 Mar;30(3):674-82. doi: 10.1038/leu.2015.294. Epub 2015 Oct 26.

PMID:
26500142
16.

CD200 in High-Grade Lymphoma, Chronic Lymphocytic Leukemia, and Chronic Lymphocytic Leukemia-Phenotype Monoclonal B-Cell Lymphocytosis.

Sorigue M, Junca J, Granada I.

Am J Clin Pathol. 2015 Oct;144(4):677-9. doi: 10.1309/AJCPO2KKFHOEXNZF. No abstract available.

PMID:
26386092
17.

Clinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia.

Ruiz-Xivillé N, Granada I, Campos D, Cisneros A, Grau J, Xandri M, Arnan M, Lloveras N, Escoda L, Font L, Millá F, Ribera JM.

Leuk Lymphoma. 2015;56(9):2706-8. doi: 10.3109/10428194.2014.1003053. Epub 2015 Feb 20. No abstract available.

PMID:
25549805
18.

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.

Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, González-Campos J, Fernández-Abellán P, Tormo M, Bethencourt C, Brunet S, Hernández-Rivas JM, Moreno MJ, Sarrà J, Del Potro E, Barba P, Bernal T, Grande C, Grau J, Cervera J, Feliu E; PETHEMA Group, Spanish Society of Hematology.

Cancer. 2014 Dec 15;120(24):3958-64. doi: 10.1002/cncr.28950. Epub 2014 Aug 12.

19.

Translocation (18;22)(q21;q11.2) in B-cell lymphoproliferative disorders: a report of six cases.

Britos-Franco P, Rodríguez-Hernández I, Navarro JT, Granada I, Tapia G, Juncà J, Ribera JM, Millá F.

Leuk Lymphoma. 2015 Mar;56(3):789-92. doi: 10.3109/10428194.2014.928932. Epub 2014 Jul 17. No abstract available.

PMID:
24884313
20.

Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis.

Juncà J, Garcia-Caro M, Granada I, Rodríguez-Hernández I, Torrent A, Morgades M, Ribera JM, Millá F, Feliu E.

Ann Hematol. 2014 Sep;93(9):1483-9. doi: 10.1007/s00277-014-2082-4. Epub 2014 Apr 29.

PMID:
24782118
21.

Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia.

Saumell S, Florensa L, Rodríguez-Rivera M, Pedro C, Hernández-Rivas JM, Lumbreras E, Abáigar M, Collado R, Ivars D, Carbonell F, Marugán I, Tormo M, Botia M, Piñan MÁ, Ancín I, González T, Varela ND, Grau J, Granada I, Ruiz N, Martín ML, Fernández-Guijarro M, Duarte JJ, Calasanz MJ, Larrayoz MJ, Solé F.

Leuk Lymphoma. 2015 Jan;56(1):242-3. doi: 10.3109/10428194.2014.914197. Epub 2014 Jun 25. No abstract available.

PMID:
24724779
22.

CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavourable acute myeloid leukemia.

Juncà J, Granada I, Rodríguez-Hernández I, Millá F.

Leuk Res. 2013 Aug;37(8):859-60. doi: 10.1016/j.leukres.2013.03.017. Epub 2013 May 18. No abstract available.

PMID:
23692656
23.

Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome.

Sánchez-Castro J, Marco-Betés V, Gómez-Arbonés X, Arenillas L, Valcarcel D, Vallespí T, Costa D, Nomdedeu B, Jimenez MJ, Granada I, Grau J, Ardanaz MT, de la Serna J, Carbonell F, Cervera J, Sierra A, Luño E, Cervero CJ, Falantes J, Calasanz MJ, González-Porrás JR, Bailén A, Amigo ML, Sanz G, Solé F.

Leuk Res. 2013 Jul;37(7):769-76. doi: 10.1016/j.leukres.2013.04.010. Epub 2013 Apr 29.

PMID:
23639672
24.

Association of JAK2 mutation status and cytogenetic abnormalities at diagnosis in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.

Zamora L, Xandri M, Garcia O, Marcé S, Xicoy B, Granada I, Navarro JT, Millá F.

Am J Clin Pathol. 2012 Apr;137(4):677-8. doi: 10.1309/AJCP74TSVUHHAJFX. No abstract available.

PMID:
22431549
25.

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Garcia-Manero G, Faderl S, Pierce S, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D.

J Clin Oncol. 2012 Mar 10;30(8):820-9. doi: 10.1200/JCO.2011.35.6394. Epub 2012 Feb 13.

26.

Scoring systems in mantle cell lymphoma: a critical point of view.

Juncà J, Ruiz-Xivillé N, Granada I, Rodríguez-Hernández I, Navarro JT, Mate JL, Millá F.

Cytometry B Clin Cytom. 2012 Mar;82(2):120-2. doi: 10.1002/cyto.b.20620. Epub 2011 Sep 13.

27.

[Therapy-related acute leukemia: study of 23 pacients].

Motlló C, Sancho JM, García O, Granada I, Millá F, Ribera JM.

Med Clin (Barc). 2011 Oct 15;137(10):449-52. doi: 10.1016/j.medcli.2010.09.052. Epub 2011 Jun 22. Spanish.

PMID:
21696789
28.

Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.

Motlló C, Grau J, Juncà J, Ruiz N, Mate JL, Orna E, Navarro JT, Vives S, Sancho JM, Esteban D, Granada I, Feliu E, Ribera JM, Millá F.

Cancer Genet Cytogenet. 2010 Dec;203(2):328-32. doi: 10.1016/j.cancergencyto.2010.08.018.

PMID:
21156254
29.

[From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome].

Hernández JM, Granada I, Solé F; en representación del Grupo Cooperativo Español de Citogenética Hematólogica.

Med Clin (Barc). 2011 Jul 23;137(5):221-9. doi: 10.1016/j.medcli.2010.04.016. Epub 2010 Jun 29. Review. Spanish.

PMID:
20591449
30.

New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY).

Baró C, Salido M, Espinet B, Astier L, Domingo A, Granada I, Millà F, Carrió A, Costa D, Luño E, Hernández JM, Campo E, Florensa L, Ferrer A, Salar A, Bellosillo B, Besses C, Serrano S, Solé F.

Leuk Res. 2008 May;32(5):727-36. Epub 2007 Nov 19.

PMID:
18023866
31.

Presenting features of 201 children with acute lymphoblastic leukemia: comparison according to presence or absence of ETV6/RUNX1 rearrangement.

Alvarez Y, Caballín MR, Gaitán S, Pérez A, Bastida P, Ortega JJ, Cervera J, Verdeguer A, Tasso M, Aventín A, Badell I, Guitart M, Melo M, Granada I, Javier G, Dastugue N, Robert A, Coll MD.

Cancer Genet Cytogenet. 2007 Sep;177(2):161-3. No abstract available.

PMID:
17854676
32.

Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.

Navarro JT, Feliu E, Grau J, Espinet B, Colomer D, Ribera JM, Oriol A, Granada I, Juncà J, Millá F.

Am J Hematol. 2007 Sep;82(9):849-51.

33.

Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma.

Baró C, Salido M, Domingo A, Granada I, Colomo L, Serrano S, Solé F.

Haematologica. 2006 Sep;91(9):1289-91.

34.

CD5 negative and CD5 positive splenic marginal B-cell lymphomas have differential cytogenetic patterns.

Gimeno E, Salido M, Solé F, Florensa L, Granada I, Domingo A, Woessner S.

Leuk Res. 2005 Aug;29(8):981-2. No abstract available.

PMID:
15978952
35.

Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia.

Casas S, Aventín A, Fuentes F, Vallespí T, Granada I, Carrió A, Angel Martínez-Climent J, Solé F, Teixidó M, Bernués M, Duarte J, Maria Hernández J, Brunet S, Dolors Coll M, Sierra J.

Cancer Genet Cytogenet. 2004 Aug;153(1):16-25.

PMID:
15325089
36.

Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma.

Mate JL, Navarro JT, Ariza A, Ribera JM, Castellà E, Juncà J, Tural C, Nomdedeu JF, Bellosillo B, Serrano S, Granada I, Millá F, Feliu E.

Hum Pathol. 2004 May;35(5):632-5.

PMID:
15138941
37.

Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia.

Lloveras E, Granada I, Zamora L, Espinet B, Florensa L, Besses C, Xandri M, Pérez-Vila ME, Millà F, Woessner S, Solé F.

Cancer Genet Cytogenet. 2004 Jan 1;148(1):71-6.

PMID:
14697644
38.

Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine.

Navarro JT, Ribera JM, Mate JL, Granada I, Juncà J, Batlle M, Millá F, Feliu E.

Leuk Lymphoma. 2003 Mar;44(3):531-3.

PMID:
12688327
39.

Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings.

Abella E, Feliu E, Granada I, Millá F, Oriol A, Ribera JM, Sánchez-Planell L, Berga LI, Reverter JC, Rozman C.

Am J Clin Pathol. 2002 Oct;118(4):582-8.

PMID:
12375646
40.

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF; PETHEMA Group, Spanish Society of Hematology.

Haematologica. 2002 Feb;87(2):154-66.

41.

Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.

Solé F, Salido M, Espinet B, Garcia JL, Martinez Climent JA, Granada I, Hernández JM, Benet I, Piris MA, Mollejo M, Martinez P, Vallespí T, Domingo A, Serrano S, Woessner S, Florensa L.

Haematologica. 2001 Jan;86(1):71-7.

42.

Translocation (3;10)(q26;q22): a new nonrandom abnormality in three patients with 3q26 involvement.

Granada I, Luño E, Ribera JM, Sanzo C, Muñiz SG, Millá F.

Cancer Genet Cytogenet. 2000 Aug;121(1):99-100. No abstract available.

PMID:
10991622
43.

Myelofibrosis in myeloid malignancies with 3q26 cytogenetic abnormalities.

Sancho JM, Ribera JM, Granada I, Navarro JT, Millá F, Feliu E.

Haematologica. 2000 May;85(5):554-5. No abstract available.

44.

Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo.

Hernández JM, González MB, Granada I, Gutiérrez N, Chillón C, Ramos F, Ribera JM, González M, Feliu E, San Miguel J.

Haematologica. 2000 May;85(5):481-5.

45.

Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogenética Hematológica.

Solé F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luño E, Prieto F, Granada I, Hernández JM, Cigudosa JC, Diez JL, Bureo E, Marqués ML, Arranz E, Ríos R, Martínez Climent JA, Vallespí T, Florensa L, Woessner S.

Br J Haematol. 2000 Feb;108(2):346-56.

PMID:
10691865
46.

[Changes in the long arm of chromosome 3 (3q) in malignant myeloid hemopathies. A study of 10 cases].

Sancho JM, Granada I, Ribera JM, Batlle M, Hernández JA, Navarro JT, Fernández F, Millá F, Feliu E.

Med Clin (Barc). 1999 Apr 17;112(13):499-502. Spanish.

PMID:
10353117
47.

Acute promyelocytic leukemia in a patient with idiopathic myelofibrosis.

Batlle M, Fernández-Avilés F, Ribera JM, Millá F, Granada I, Gómez Espuch J, Navarro JT, Feliu E.

Leukemia. 1999 Mar;13(3):492-4. No abstract available.

48.

[A comparison of the results of cytogenetic studies in de novo and secondary acute myeloblastic leukemias. A study of 69 patients].

Granada I, Ribera JM, Millá F, Feliu E.

Med Clin (Barc). 1999 Jan 23;112(2):77-8. Spanish. No abstract available.

PMID:
10065437
49.

Acute promyelocytic leukemia in a HIV seropositive patient.

Calvo R, Ribera JM, Battle M, Sancho JM, Granada I, Flores A, Millá F, Feliu E.

Leuk Lymphoma. 1997 Aug;26(5-6):621-4.

PMID:
9389370
50.

[Acute myelomonocytic leukemia with eosinophilia and inversion of chromosome 16. Study of 6 cases].

Calvo R, Ribera JM, Millá F, Granada I, Orts M, Batlle M, Flores A, Juncà J, Feliu E.

Med Clin (Barc). 1997 Feb 8;108(5):182-5. Spanish.

PMID:
9091723

Supplemental Content

Loading ...
Support Center